Warning
Lannett Company Inc. Recalls Dextroamphetamine Saccharate
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0660-2026Drug / Pharmaceutical
Lannett Company Inc. Recalls Dextroamphetamine Saccharate
Lannett Company Inc. · Class II — Moderate Risk
Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
Reason for Recall
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
US Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Lannett Company Inc. has recalled a pharmaceutical product that the FDA classified as Class II affecting 1392 bottles. The recall was initiated on June 26, 2026. Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. It was distributed in US Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.